Thus, in T2D patients, β cells are exposed to two counteracting stimuli, glucagon‐induced hepatic glucose production, and hyperglycemia stimulation, whereas KP production inhibits glucose‐stimulated insulin secretion. Here, INS is linked to type 2 diabetes mellitus.